In the last 12 months, insiders at TherapeuticsMD made open-market purchases of $14,031 (8.4K shares) and sold no shares on the open market.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Capital Management Lp Rubric | Director, TenPercentOwner, Other | 0 | 4,689,274 | 4,689,274 | 94.7% | 15 Nov, 2023 |
| 2 | Marlan D Walker | Chief Executive Officer | 73,639 | 0 | 73,639 | 1.5% | 15 Apr, 2025 |
| 3 | Michael C Donegan | Prin. Fin. And Acctg. Officer | 61,853 | 0 | 61,853 | 1.2% | 14 Apr, 2023 |
| 4 | Cooper C. Collins | Director | 60,516 | 0 | 60,516 | 1.2% | 20 Feb, 2025 |
| 5 | Tommy G Thompson | Director | 23,179 | 0 | 23,179 | 0.5% | 29 Dec, 2025 |
| 6 | Gail K Naughton | Director | 8,500 | 0 | 8,500 | 0.2% | 20 Feb, 2025 |
| 7 | Joseph Ziegler | Principal Financial Officer | 7,500 | 0 | 7,500 | 0.2% | 21 Aug, 2023 |
| 8 | Paul Bisaro | Director | 5,922 | 0 | 5,922 | 0.1% | 22 Aug, 2022 |
| 9 | Angus C. Russell | Director | 5,792 | 0 | 5,792 | 0.1% | 22 Aug, 2022 |
| 10 | Karen Ling | Director | 4,591 | 0 | 4,591 | 0.1% | 22 Aug, 2022 |
| 11 | Jules A. Musing | Director | 4,022 | 0 | 4,022 | 0.1% | 22 Aug, 2022 |
| 12 | Brian Bernick | Co Chief Executive Officer | 3,872 | 0 | 3,872 | 0.1% | 09 Dec, 2022 |
| 13 | Mark A Glickman | Co Chief Executive Officer | 1,294 | 0 | 1,294 | 0.0% | 09 Dec, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 23 Dec, 2025 | Tommy G Thompson | Director | Acquired P | 8,400 | $1.67 | $14.03K | 23,179 | Direct |
| 03 Nov, 2025 | Tommy G Thompson | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 03 Nov, 2025 | Gail K Naughton | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 03 Nov, 2025 | Cooper C. Collins | Director | Acquired A | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 03 Nov, 2025 | Marlan D Walker | Chief Executive Officer | Acquired A | 67,492 | $0.00 | $0 | 67,492 | Direct |
| 14 Apr, 2025 | Tommy G Thompson | Director | Acquired P | 325 | $1.00 | $326 | 14,779 | Direct |
| 14 Apr, 2025 | Marlan D Walker | Chief Executive Officer | Acquired P | 490 | $1.00 | $489 | 73,639 | Direct |
| 09 Apr, 2025 | Marlan D Walker | Chief Executive Officer | Acquired P | 1,136 | $0.87 | $994 | 71,982 | Direct |
| 10 Apr, 2025 | Marlan D Walker | Chief Executive Officer | Acquired P | 1,167 | $0.86 | $1.00K | 73,149 | Direct |
| 18 Feb, 2025 | Tommy G Thompson | Director | Acquired M | 8,500 | $0.00 | $0 | 14,454 | Direct |
| 18 Feb, 2025 | Gail K Naughton | Director | Acquired M | 8,500 | $0.00 | $0 | 8,500 | Direct |
| 18 Feb, 2025 | Cooper C. Collins | Director | Acquired M | 8,500 | $0.00 | $0 | 60,516 | Direct |
| 18 Feb, 2025 | Marlan D Walker | Chief Executive Officer | Acquired M | 3,467 | $0.00 | $0 | 66,032 | Direct |
| 18 Feb, 2025 | Gail K Naughton | Director | Disposed M | 8,500 | $0.00 | $0 | 0 | Direct |
| 18 Feb, 2025 | Cooper C. Collins | Director | Disposed M | 8,500 | $0.00 | $0 | 0 | Direct |
| 18 Feb, 2025 | Marlan D Walker | Chief Executive Officer | Acquired M | 2,311 | $0.00 | $0 | 68,343 | Direct |
| 18 Feb, 2025 | Marlan D Walker | Chief Executive Officer | Acquired M | 770 | $0.00 | $0 | 69,113 | Direct |
| 18 Feb, 2025 | Marlan D Walker | Chief Executive Officer | Acquired M | 1,733 | $0.00 | $0 | 70,846 | Direct |
| 18 Feb, 2025 | Tommy G Thompson | Director | Disposed M | 8,500 | $0.00 | $0 | 0 | Direct |
| 18 Feb, 2025 | Marlan D Walker | Chief Executive Officer | Disposed M | 3,467 | $0.00 | $0 | 0 | Direct |